Search

Your search keyword '"Ruth De Francisco"' showing total 14 results
Start Over Author "Ruth De Francisco" Publication Year Range Last 3 years
14 results on '"Ruth De Francisco"'

1. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

Author

Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa de Castro, Ruth De Francisco, Francisco Javier García-Alonso, Ana Sanahuja, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Míriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra-Ausin, Carlos González-Muñoza, Xavier Calvet, Santiago García-López, Jordi Guardiola, Lara Arias García, Lucía Márquez-Mosquera, Ana Gutiérrez, Yamile Zabana, Mercè Navarro-Llavat, Rufo Lorente Poyatos, Marta Piqueras, Leyanira Torrealba, Fernando Bermejo, Ángel Ponferrada-Díaz, José L. Pérez-Calle, Manuel Barreiro-de Acosta, Coral Tejido, José Luis Cabriada, Ignacio Marín-Jiménez, Óscar Roncero, Yolanda Ber, Luis Fernández-Salazar, Blau Camps Aler, Alfredo J. Lucendo, Jordina Llaó, Luis Bujanda, Carmen Muñoz Villafranca, Eugeni Domènech, María Chaparro, and Javier P. Gisbert

Subjects
biologics, biosimilars, targeted therapy, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, Pharmacy and materia medica, RS1-441
Abstract

Markers that allow for the selection of tailored treatments for individual patients with inflammatory bowel diseases (IBD) are yet to be identified. Our aim was to describe trends in real-life treatment usage. For this purpose, patients from the ENEIDA registry who received their first targeted IBD treatment (biologics or tofacitinib) between 2015 and 2021 were included. A subsequent analysis with Machine Learning models was performed. The study included 10,009 patients [71% with Crohn’s disease (CD) and 29% with ulcerative colitis (UC)]. In CD, anti-TNF (predominantly adalimumab) were the main agents in the 1st line of treatment (LoT), although their use declined over time. In UC, anti-TNF (mainly infliximab) use was predominant in 1st LoT, remaining stable over time. Ustekinumab and vedolizumab were the most prescribed drugs in 2nd and 3rd LoT in CD and UC, respectively. Overall, the use of biosimilars increased over time. Machine Learning failed to identify a model capable of predicting treatment patterns. In conclusion, drug positioning is different in CD and UC. Anti-TNF were the most used drugs in IBD 1st LoT, being adalimumab predominant in CD and infliximab in UC. Ustekinumab and vedolizumab have gained importance in CD and UC, respectively. The approval of biosimilars had a significant impact on treatment.

Published
2024
Full Text
View/download PDF

2. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

Author

Ana Gutiérrez, Pedro Zapater, Elena Ricart, María González-Vivó, Jordi Gordillo, David Olivares, Isabel Vera, Míriam Mañosa, Javier P. Gisbert, Mariam Aguas, Eugenia Sánchez-Rodríguez, Maia Bosca-Watts, Viviana Laredo, Blau Camps, Ignacio Marín-Jiménez, Yamile Zabana, María Dolores Martín-Arranz, Roser Muñoz, Mercè Navarro, Eva Sierra, Lucía Madero, Milagros Vela, José Lázaro Pérez-Calle, Empar Sainz, Xavier Calvet, Lara Arias, Victor Morales, Fernando Bermejo, Luis Fernández-Salazar, Manuel Van Domselaar, Luisa De Castro, Cristina Rodríguez, Carmen Muñoz-Villafranca, Rufo Lorente, Montserrat Rivero, Eva Iglesias, Belén Herreros, David Busquets, Joan Riera, María Pilar Martínez-Montiel, Marta Roldón, Oscar Roncero, Esther Hinojosa, Mónica Sierra, Jesús Barrio, Ruth De Francisco, José Huguet, Olga Merino, Daniel Carpio, Daniel Ginard, Fernando Muñoz, Marta Piqueras, Pedro Almela, Federico Argüelles-Arias, Guillermo Alcaín, Luis Bujanda, Noemí Manceñido, Alfredo J. Lucendo, Pilar Varela, Iago Rodríguez-Lago, Laura Ramos, Laura Sempere, Eva Sesé, Manuel Barreiro-de Acosta, Eugeni Domènech, and Rubén Francés

Subjects
immigrant, phenotype, biologics, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Medicine (General), R5-920
Abstract

BackgroundPrevious studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and phenotypic differences. To date, no study has focused on the immigrant IBD population in Spain.MethodsProspective, observational, multicenter study comparing cohorts of IBD patients from ENEIDA-registry who were born outside Spain with a cohort of native patients.ResultsWe included 13,524 patients (1,864 immigrant and 11,660 native). The immigrants were younger (45 ± 12 vs. 54 ± 16 years, p < 0.001), had been diagnosed younger (31 ± 12 vs. 36 ± 15 years, p < 0.001), and had a shorter disease duration (14 ± 7 vs. 18 ± 8 years, p < 0.001) than native patients. Family history of IBD (9 vs. 14%, p < 0.001) and smoking (30 vs. 40%, p < 0.001) were more frequent among native patients. The most prevalent ethnic groups among immigrants were Caucasian (41.5%), followed by Latin American (30.8%), Arab (18.3%), and Asian (6.7%). Extraintestinal manifestations, mainly musculoskeletal affections, were more frequent in immigrants (19 vs. 11%, p < 0.001). Use of biologics, mainly anti-TNF, was greater in immigrants (36 vs. 29%, p < 0.001). The risk of having extraintestinal manifestations [OR: 2.23 (1.92–2.58, p < 0.001)] and using biologics [OR: 1.13 (1.0–1.26, p = 0.042)] was independently associated with immigrant status in the multivariate analyses.ConclusionsCompared with native-born patients, first-generation-immigrant IBD patients in Spain were younger at disease onset and showed an increased risk of having extraintestinal manifestations and using biologics. Our study suggests a featured phenotype of immigrant IBD patients in Spain, and constitutes a new landmark in the epidemiological characterization of immigrant IBD populations in Southern Europe.

Published
2022
Full Text
View/download PDF

3. Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The <scp>ADA‐SWITCH</scp> study

Author

María José Casanova, Óscar Nantes, Pilar Varela, Milagros Vela‐González, Montserrat Rivero, Olivia Sierra‐Gabarda, Sabino Riestra, Manuel Barreiro‐de Acosta, María del Mar Martín‐Rodríguez, Carla Jerusalén Gargallo‐Puyuelo, Cristina Reygosa, Roser Muñoz, Irene García de la Filia‐Molina, Andrea Núñez‐Ortiz, Lilyan Kolle, Margalida Calafat, José María Huguet, Eva Iglesias‐Flores, Teresa de Jesús Martínez‐Pérez, Orencio Bosch, José María Duque‐Alcorta, Santiago Frago‐Larramona, Manuel Van Domselaar, Víctor Manuel González‐Cosano, Luis Bujanda, Saioa Rubio, Alejo Mancebo, Beatriz Castro, Santiago García‐López, Ruth de Francisco, Laura Nieto‐García, Viviana Laredo, Ana Gutiérrez‐Casbas, Francisco Mesonero, Eduardo Leo‐Carnerero, Fiorella Cañete, Lucía Ruiz, Beatriz Gros, María del Moral‐Martínez, Cristina Rodríguez, María Chaparro, and Javier P. Gisbert

Subjects
Hepatology, Gastroenterology, Pharmacology (medical)
Published
2023
Full Text
View/download PDF

4. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

Author

Manuel Barreiro-de, Acosta, Agnès, Fernández-Clotet, Francisco, Mesonero, Francisco Javier, García-Alonso, María José, Casanova, Margarita, Fernández-de la Varga, Fiorella, Cañete, Luisa, de Castro, Ana, Gutiérrez, Beatriz, Sicilia, Victoria, Cano, Olga, Merino, Ruth, de Francisco, Irene, González-Partida, Gerard, Surís, Leyanira, Torrealba, Rocío, Ferreiro-Iglesias, Beatriz, Castro, Lucía, Márquez, Ana, Sobrino, Ainara, Elorza, Xavier, Calvet, Pilar, Varela, Raquel, Vicente, Luis, Bujanda, Laura, Lario, Noemí, Manceñido, Mariana F, García-Sepulcre, Eva, Iglesias, Cristina, Rodríguez, Marta, Piqueras, Juan Ángel, Ferrer Rosique, Alfredo J, Lucendo, Olga, Benítez, Melody, García, David, Olivares, Carlos, González-Muñoza, Beatriz, López-Cauce, Victor Jair, Morales Alvarado, Katerina, Spicakova, Alicia, Brotons, Fernando, Bermejo, Pedro, Almela, Nahia, Ispízua, Pau, Gilabert, Carlos, Tardillo, Fernando, Muñoz, Pablo, Navarro, Rosa Eva, Madrigal Domínguez, Pau, Sendra, Esther, Hinojosa, Empar, Sáinz, María Dolores, Martín-Arranz, Daniel, Carpio, Elena, Ricart, Berta, Caballol, Laura, Núñez, Jesús, Barrio, Javier P, Gisbert, Marisa, Iborra, Margalida, Calafat, Vicent, Hernández, Roser Muñoz, Pérez, José Luis, Cabriada, Eugeni, Domènech, and Iago, Rodríguez-Lago

Subjects
Hepatology, Gastroenterology
Abstract

The prevalence of penetrating complications in Crohn's disease (CD) increases progressively over time, but evidence on the medical treatment in this setting is limited. The aim of this study was to evaluate the effectiveness of biologic agents in CD complicated with internal fistulizing disease.Adult patients with CD-related fistulae who received at least one biologic agent for this condition from the prospectively-maintained ENEIDA registry were included. Exclusion criteria involved those receiving biologics for perianal disease, enterocutaneous, rectovaginal, anastomotic or periostomal fistulae. The primary endpoint was fistula-related surgery. Predictive factors associated with surgery and fistula closure were evaluated by multivariate logistic regression and survival analyses.A total of 760 patients from 53 hospitals (673 receiving anti-TNFs, 69 ustekinumab, and 18 vedolizumab) were included. After a median follow-up of 56 months (IQR, 26-102), 240 patients required surgery, with surgery rates of 32%, 41%, 24% among those under anti-TNF, vedolizumab, or ustekinumab, respectively. Fistula closure was observed in 24% of patients. Older patients, ileocolonic disease, entero-urinary fistulae, or an intestinal stricture distal to the origin of the fistula were associated with a higher risk of surgery, while non-smokers, and combination therapy with an immunomodulator reduced this risk.Biologic therapy is beneficial in approximately three quarters of patients with fistulizing CD, achieving fistula closure in 24%. However, around one third still undergo surgery due to refractory disease. Some patient and lesion-related factors can identify patients who will obtain more benefit from these drugs.

Published
2023
Full Text
View/download PDF

5. Crohn's Disease induced by Ocrelizumab in a patient with multiple sclerosis

Author

Lorena Carballo-Folgoso, Miriam Celada-Sendino, Andrés Castaño-García, Pedro Oliva Nacarino, Patricia Morales del Burgo, Isabel Pérez-Martínez, Ruth de Francisco, and Sabino Riestra

Subjects
Gastroenterology, General Medicine
Abstract

Drug-induced inflammatory bowel disease (IBD) is a clinical entity on the rise due to the frequent use of immunomodulatory therapy. Here we report the case of Crohn's disease due to Ocrelizumab, a humanized anti-CD20 monoclonal antibody approved for the treatment of multiple sclerosis. The exact mechanism by which anti-CD20 antibodies can trigger IBD is unknown, but since IBD and multiple sclerosis are processes included within the spectrum of immunomediated diseases, we could suggest that Ocrelizumab could trigger IBD in genetically predisposed patients.

Published
2022

6. Recurrent abdominal pain as the only clinical manifestation of hereditary angiodema type II

Author

Daniel Muíño-Domínguez, Lorena Carballo-Folgoso, Luis Martínez Camblor, Marta García Calonge, Maria Helena González Sánchez, Isabel Pérez-Martínez, Ruth de Francisco, and Sabino Riestra

Subjects
Gastroenterology, General Medicine
Abstract

Recurrent abdominal pain is a common reason for consultation in Gastroenterology. The differential diagnosis includes hereditary angioedema (HAE), a rare disorder characterized by recurrent episodes of angioedema, without urticaria or pruritus, which most often affects the skin, but also mucosal tissues of the gastrointestinal tract, triggered by diverse factors such as infections, trauma, surgery, drugs, or stress. It is a disease with a difficult diagnosis due to its heterogeneous and transitory clinical features, so having a clinical suspicion in the appropriate context would allow the administration of a specific treatment and avoid unnecessary examinations. We present the case of a 19-year-old male followed-up for recurrent abdominal pain that, after numerous microbiological, endoscopic, and radiological examinations, complement tests were requested, obtaining low levels of C4 with increased levels of C1 inhibitor and reduced functional activity, being diagnosed with HAE type II.

Published
2022

7. 36 - EFECTIVIDAD Y SEGURIDAD DE LA TERAPIA CON USTEKINUMAB Y VEDOLIZUMAB EN PACIENTES CON FÍSTULA PERIANAL COMPLEJA: ESTUDIO HEAL

Author

María José Casanova, María Chaparro, Berta Caballol, María José García, Francisco Mesonero, Cristina Rubín de Célix, Patricia Suárez-álvarez, Rocío Ferreiro-Iglesias, María del Mar Martín-Rodríguez, Ruth de Francisco, Pilar Varela-Trastoy, Guillermo Bastida, Marta Carrillo-Palau, Andrea Núñez-Ortiz, Patricia Ramírez-de la Piscina, Daniel Ceballos, Daniel Hervías-Cruz, Roser Muñoz-Pérez, Benito Velayos, Fernando Bermejo, David Busquets, Manuel Cabacino, Patricia Camo-Monteverde, Ignacio Marín-Jiménez, Carmen Muñoz, Luisa Carmen de la Peña-Negro, Eva Sierra-Moros, Jesús Barrio, Eduard Brunet-Mas, Luis Bujanda, Fiorella Cañete, Fernando Gomollón, Noemí Manceñido-Marcos, Iago Rodríguez-Lago, María Carmen Rodríguez-Grau, Beatriz Sicilia, Sandra Torra-Alsina, Laura Arranz-Hernández, Daniel Carpio, Mariana Fe García-Sepulcre, Carlos González-Muñoza, José María Huguet, Lucía Márquez-Mosquera, María Pilar López-Serrano, Ángel Ponferrada-Díaz, and Javier P. Gisbert

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

8. 33 - LA INFECCIÓN POR VIH SE ASOCIA CON UN FENOTIPO MENOS AGRESIVO DE ENFERMEDAD INFLAMATORIA INTESTINAL. ESTUDIO MULTICÉNTRICO BASADO EN EL REGISTRO ENEIDA

Author

Margalida Calafat, Carles Súria, Francisco Mesonero, Ruth de Francisco, Carmen Yagüe Caballero, Luisa de la Peña, Alejandro Hernández- Camba, Ainhoa Marcè, Beatriz Gallego Llera, Noelia Martín-Vicente, Montserrat Rivero, Marisa Iborra, Iván Guerra, Marta Carrillo-Palau, Lucía Madero, Beatriz Burgueño, David Montfort, Gisela Torres, Marta Teller, Juan Ángel Ferrer Rosique, Pablo Vega Villaamil, Cristina Roig, Ángel Ponferrada, Elena Betoré Glaría, Yamile Zabana, Javier P. Gisbert, David Busquets, Noelia Alcaide, Blau Camps, Jesús Legido, Maria González Vivo, Marta Maia Bosca-Watts, Isabel Pérez-Martínez, Diego Casas Deza, Jordi Guardiola, Laura Arranz Hernández, Mercè Navarro-Llavat, Fernando Gomollón, Fiorella Cañete, Míriam Mañosa, and Eugeni Domènech

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

9. 52 - PRESENTACIÓN CLÍNICA, MANEJO Y EVOLUCIÓN DE LOS LINFOMAS EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL: ESTUDIO NACIONAL BASADO EN EL REGISTRO ENEIDA

Author

Iván Guerra, Luis Bujanda, Miriam Mañosa, Isabel Pérez Martínez, María José Casanova, Luisa de la Peña, Marina de Benito, Montserrat Rivero, Pilar Varela, Lorena Bernal, Ana Carolina Franco, Yolanda Ber, Marta Piqueras, Carlos Tardillo, Ángel Ponferrada, Sonsoles Olivares, Alfredo J. Lucendo, Pau Gilabert, Mónica Sierra Ausín, María Bellart, Amaia Herrarte, Margalida Calafat, Ruth de Francisco, Javier P. Gisbert, Jordi Guardiola, Eugeni Domènech, and Fernando Bermejo

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

10. 67 - PSORIASIS INDUCIDA POR TERAPIA ANTI-TNF EN ENFERMEDAD INFLAMATORIA INTESTINAL: ANÁLISIS DEL MANEJO TERAPÉUTICO Y EVOLUCIÓN DE AMBAS ENFERMEDADES EN UN ESTUDIO DE COHORTES A NIVEL NACIONAL

Author

Patricia Sanz Segura, Fernando Gomollón, Víctor Argumánez, Milagros Vela, Agnès Fernández-Clotet, Roser Muñoz, Irene García de la Filia, María García Prada, Juan Ángel Ferrer Rosique, María José García, Ruth de Francisco, Lara Arias, Jesús Barrio, Iván Guerra, Ángel Ponferrada Diaz, Javier P. Gisbert, Marta Carrillo-Palau, Xavier Calvet, Lucía Márquez- Mosquera, Beatriz Gros, Fiorella Cañete, David Monfort, Rosa Eva Madrigal Domínguez, Óscar Roncero, Viviana Laredo, Miguel Montoro, Carmen Muñoz, Beatriz López-Cauce, Rufo Lorente, Ana Fuentes Coronel, Pablo Vega, María Dolores Martín-Arranz, Elena Peña, Pilar Varela, Diego Casas-Deza, Sonsoles Olivares, Ramón Pajares, Alfredo J. Lucendo, Eva Sesé Abizanda, Belén Botella Mateu, Sonia García García, Eugeni Domènech, and Santiago García-López

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

11. 34 - POSICIONAMIENTO DE LAS TERAPIAS DIRIGIDAS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL (EII) EN VIDA REAL: ESTUDIO TRENDY DEL REGISTRO ENEIDA

Author

Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, M. Dolores Martín-Arranz, Luisa de Castro, Ruth de Francisco, Francisco Javier García-Alonso, Ana Sanahuja Martínez, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Miriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra-Ausin, Carlos González-Muñoza, Xavier Calvet, Santiago García-López, Jordi Guardiola, Lara Arias García, Lucía Márquez-Mosquera, Ana Gutiérrez, Yamile Zabana, Merce Navarro, Rufo Lorente Poyatos, Marta Piqueras, Leyanira Torrealba, Fernando Bermejo, Ángel Ponferrada Díaz, José L Pérez-Calle, Manuel Barreiro-de Acosta, Coral Tejido, José Luis Cabriada, Ignacio Marín-Jiménez, Óscar Roncero, Yolanda Ber, Luis Fernández-Salazar, Blau Camps Aler, Alfredo J Lucendo Villarín, Jordina Llaó, Luis Bujanda, Carmen Muñoz Villafranca, Eugeni Domènech, María Chaparro, and Javier P. Gisbert

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

12. 59 - FACTORES DE RIESGO PARA EL DESARROLLO DE ENFERMEDAD CARDIOVASCULAR (CARDIOPATÍA ISQUÉMICA Y ACCIDENTE CEREBROVASCULAR) EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL: UNA COHORTE HOSPITALARIA

Author

Daniel Muíño Domínguez, Lorena Carballo Folgoso, Jorge Ortega Carriedo, Pablo Flórez Díez, Ruth de Francisco, Isabel Pérez Martínez, Andrés Castaño García, Emilia Fernández García, Cristina García Pérez, Susana Martínez González, Valeria Rolle, and Sabino Riestra

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

13. 49 - PREDICCIÓN DEL RIESGO FARMACOGENÉTICO DE PANCREATITIS AGUDA POR TIOPURINAS EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL: ESTUDIO CASO-CONTROL BASADO EN EL REGISTRO ENEIDA

Author

Iván Guerra, Francisco Barros, María Chaparro, José M. Benítez, María Dolores Martín Arranz, Ruth de Francisco, Marta Piqueras, Luisa de Castro, Ana Y. Carbajo, Fernando Bermejo, Miguel Mínguez, Ana Gutiérrez, Francisco Mesonero, Fiorella Cañete, Carlos González-Muñoza, Marta Calvo, Beatriz Sicilia, Erika Alfambra, Carlos A. Tardillo, Montserrat Rivero, Alfredo J. Lucendo, Luis Bujanda, Manuel van Domselaar, Pedro Almela, Laura Ramos, María Fernández Sánchez, Esther Hinojosa, Cristina Verdejo, Anna Gimenez, Iago Rodríguez-Lago, Noemí Manceñido, José L. Pérez Calle, Mónica del Pilar Moreno, Pedro Genaro Delgado- Guillena, Beatriz Antolín, Patricia Ramírez de la Piscina, M.J. Casanova, Pilar Soto Escribano, Eduardo Martín Arranz, Isabel Pérez Martínez, Raquel Mena, Natalia García Morales, Alicia Granja, Marta Maia Bosca Watts, Rubén Francés, Cristina Fernández, Margalida Calafat, Cristina Roig-Ramos, María Isabel Vera Mendoza, Ángel Carracedo, Eugeni Domènech, and Javier P. Gisbert

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

14. ¿ES FACTIBLE LA SUSPENSIÓN DEL TRATAMIENTO ANTI-TNF EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL EN REMISIÓN SIN AUMENTAR EL RIESGO DE RECIDIVA? RESULTADOS DEL ENSAYO CLÍNICO ALEATORIZADO DE GETECCU (EXIT)

Author

María Chaparro, María García Donday, Sabino Riestra, Alfredo J Lucendo, José Manuel Benítez, Mercè Navarro-Llavat, Jesús Barrio, Víctor J. Morales-Alvarado, Montserrat Rivero, David Busquets, Eduardo Leo Carnerero, Olga Merino Ochoa, Óscar Nantes Castillejo, Pablo Navarro, Manuel van Domselaar, Ana Gutiérrez Casbas, Inmaculada Alonso-Abreu, Rafael Mejuto, Luis Fernández Salazar, Marisa Iborra, María Dolores Martín-Arranz, Juan Ramón Pineda, Manuela Josefa Sampedro, Katja Serra Nilsson, Abdel Bouhmidi Assakali, Lissette Batista, Carmen Muñoz Villafranca, Iago Rodríguez-Lago, Daniel Sebastián Ceballos Santos, Iván Guerra, Miriam Mañosa, Ignacio Marín Jiménez, Emilio Torrella, Isabel Vera Mendoza, María José Casanova, Ruth de Francisco, Laura Arias-González, Sandra Marín Pedrosa, Orlando García-Bosch, Francisco Javier García-Alonso, Pedro Delgado- Guillena, María José García, Leyanira Torrealba, Andrea Núñez-Ortiz, Miren Vicuña Arregui, Marta Maia Bosca-Watts, Isabel Blázquez, Diana Acosta, Ana Garre, Concepción Martínez, Manuel Barreiro-de Acosta, Eugeni Domènech, María Esteve, Valle García-Sánchez, Pilar Nos, Julian Panés, and Javier P. Gisbert

Subjects
Hepatology, Gastroenterology
Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results